Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Cyclerion Therapeutics (CYCN) Accumulated Depreciation & Amortization (2019 - 2022)

Cyclerion Therapeutics (CYCN) has 4 years of Accumulated Depreciation & Amortization data on record, last reported at $2.2 million in Q4 2022.

  • For Q4 2022, Accumulated Depreciation & Amortization fell 0.86% year-over-year to $2.2 million; the TTM value through Dec 2022 reached $2.2 million, down 0.86%, while the annual FY2022 figure was $2.2 million, 0.86% down from the prior year.
  • Accumulated Depreciation & Amortization reached $2.2 million in Q4 2022 per CYCN's latest filing, down from $2.3 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $31.0 million in Q2 2019 and bottomed at $2.1 million in Q2 2021.
  • Average Accumulated Depreciation & Amortization over 4 years is $9.2 million, with a median of $2.3 million recorded in 2022.
  • Peak YoY movement for Accumulated Depreciation & Amortization: tumbled 78.61% in 2021, then rose 7.6% in 2022.
  • A 4-year view of Accumulated Depreciation & Amortization shows it stood at $21.6 million in 2019, then tumbled by 52.38% to $10.3 million in 2020, then crashed by 78.61% to $2.2 million in 2021, then fell by 0.86% to $2.2 million in 2022.
  • Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $2.2 million in Q4 2022, $2.3 million in Q3 2022, and $2.3 million in Q2 2022.